Literature DB >> 19546579

Evaluation of polymorphisms in paraoxonase 2 (PON2) gene and their association with cardiovascular-renal disease risk in Mexican Americans.

Farook Thameem1, Xin He, V Saroja Voruganti, Subrata D Nath, Paolo Fanti, John Blangero, Jean W Maccluer, Anthony G Comuzzie, Nedal H Arar, Hanna E Abboud.   

Abstract

BACKGROUND/AIMS: Genetic polymorphisms in the paraoxonase 2 (PON2) gene are thought to alter its activity and contribute to the development of cardiovascular and renal disease risk. The purpose of this study is to determine whether the Arg148Gly, Cys311Ser and rs12794795 polymorphisms of PON2 examined previously by others, are associated with type 2 diabetes (T2DM), and subclinical measures of cardiovascular and renal disease risk in Mexican Americans.
METHODS: Study participants (n = 848; 21 families) were genotyped for the three polymorphisms by TaqMan assay. Association between the genotypic and phenotypic data was performed by measured genotype approach as implemented in the variance component analytical tools.
RESULTS: The Arg148Gly variant was found to be monomorphic in our dataset. Of the phenotypes examined for association, the A/C variant located in intron-1 (rs12794795) exhibited statistically significant association only with diastolic blood pressure (p = 0.018) after accounting for the trait-specific covariate effects. The Cys311Ser variant failed to show statistically significant association with any of the phenotypes examined.
CONCLUSION: In conclusion, the variants examined at the PON2 locus in Mexican Americans do not appear to be a major contributor to T2DM, cardiovascular or renal disease risk, although they exhibited a small effect on the blood pressure values. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546579      PMCID: PMC2759102          DOI: 10.1159/000225943

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  27 in total

Review 1.  Paraoxonase genes and disease.

Authors:  R A Hegele
Journal:  Ann Med       Date:  1999-06       Impact factor: 4.709

Review 2.  Genetics of atherosclerosis risk factors in Mexican Americans.

Authors:  J W MacCluer; M P Stern; L Almasy; L A Atwood; J Blangero; A G Comuzzie; B Dyke; S M Haffner; R D Henkel; J E Hixson; C M Kammerer; M C Mahaney; B D Mitchell; D L Rainwater; P B Samollow; R M Sharp; J L VandeBerg; J T Williams
Journal:  Nutr Rev       Date:  1999-05       Impact factor: 7.110

3.  Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes.

Authors:  M Pinizzotto; E Castillo; M Fiaux; E Temler; R C Gaillard; J Ruiz
Journal:  Diabetologia       Date:  2001-01       Impact factor: 10.122

4.  PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients.

Authors:  F R Leus; M Zwart; J J Kastelein; H A Voorbij
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

5.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

6.  A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans.

Authors:  Sobha Puppala; Gerald D Dodd; Sharon Fowler; Rector Arya; Jennifer Schneider; Vidya S Farook; Richard Granato; Thomas D Dyer; Laura Almasy; Christopher P Jenkinson; Andrew K Diehl; Michael P Stern; John Blangero; Ravindranath Duggirala
Journal:  Am J Hum Genet       Date:  2006-01-06       Impact factor: 11.025

7.  Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76.

Authors:  R Calle; M I McCarthy; P Banerjee; E Zeggini; C A Cull; K I Thorne; S Wiltshire; S Terra; D Meyer; J Richmond; J Mancuso; P Milos; D Fryburg; R R Holman
Journal:  Diabetologia       Date:  2006-10-03       Impact factor: 10.122

8.  Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND).

Authors:  Jeffrey R Schelling; Hanna E Abboud; Susanne B Nicholas; Madeleine V Pahl; John R Sedor; Sharon G Adler; Nedal H Arar; Donald W Bowden; Robert C Elston; Barry I Freedman; Katrina A B Goddard; Xiuqing Guo; Robert L Hanson; Eli Ipp; Sudha K Iyengar; Gyungah Jun; W H Linda Kao; Balakuntalam S Kasinath; Paul L Kimmel; Michael J Klag; William C Knowler; Robert G Nelson; Rulan S Parekh; Shannon R Quade; Stephen S Rich; Mohammed F Saad; Marina Scavini; Michael W Smith; Kent Taylor; Cheryl A Winkler; Philip G Zager; Vallabh O Shah
Journal:  Diabetes       Date:  2007-11-14       Impact factor: 9.461

9.  The Cys(311)Ser polymorphism of paraoxonase 2 (PON2) is associated with albumin-to-creatinine ratio (ACR) in Mexican Americans.

Authors:  Farook Thameem; Sobha Puppala; Nedal H Arar; Vidya S Farook; Michael P Stern; John Blangero; Ravindranath Duggirala; Hanna E Abboud
Journal:  Nephrol Dial Transplant       Date:  2007-10-15       Impact factor: 5.992

10.  Genotype by diabetes interaction effects on the detection of linkage of glomerular filtration rate to a region on chromosome 2q in Mexican Americans.

Authors:  Sobha Puppala; Rector Arya; Farook Thameem; Nedal H Arar; Kusum Bhandari; Donna M Lehman; Jennifer Schneider; Sharon Fowler; Vidya S Farook; Vincent P Diego; Laura Almasy; John Blangero; Michael P Stern; Ravindranath Duggirala; Hanna E Abboud
Journal:  Diabetes       Date:  2007-08-13       Impact factor: 9.461

View more
  7 in total

Review 1.  Susceptibility gene search for nephropathy and related traits in Mexican-Americans.

Authors:  Farook Thameem; Issa A Kawalit; Sharon G Adler; Hanna E Abboud
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

Review 2.  Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States.

Authors:  Cristina Aguayo-Mazzucato; Paula Diaque; Sonia Hernandez; Silvia Rosas; Aleksandar Kostic; Augusto Enrique Caballero
Journal:  Diabetes Metab Res Rev       Date:  2018-12-04       Impact factor: 4.876

3.  An improved polymerase chain reaction-restriction fragment length polymorphism assay for the detection of a PON2 gene polymorphism.

Authors:  Xiaoran Duan; Yongli Yang; Tuanwei Wang; Xiaolei Feng; W U Yao; Zhen Yan; Wei Wang
Journal:  Biomed Rep       Date:  2016-05-13

Review 4.  The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases.

Authors:  Anna Wysocka; Agnieszka Zwolak
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

Review 5.  Diabetic nephropathy among Mexican Americans.

Authors:  Subrata Debnath; Farook Thameem; Tahira Alves; Jacqueline Nolen; Hania Al-Shahrouri; Shweta Bansal; Hanna E Abboud; Paolo Fanti
Journal:  Clin Nephrol       Date:  2012-04       Impact factor: 0.975

6.  Association Between Paraoxonase 2 Ser311Cys Polymorphism and Coronary Heart Disease Risk: A Meta-Analysis.

Authors:  Min-Li Chen; Hua Zhao; Ning Liao; Zheng-Fu Xie
Journal:  Med Sci Monit       Date:  2016-09-09

Review 7.  Human paraoxonase 2.

Authors:  Sureerut Porntadavity; Thinnakorn Permpongpaiboon; Wanida Sukketsiri
Journal:  EXCLI J       Date:  2010-11-26       Impact factor: 4.068

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.